Alluzience 1x125unit vial

Alluzience 1x125unit vial

Skip to product information
Alluzience 1x125unit vial

Alluzience 1x125unit vial

Prescription items are supplied only against a valid, patient-specific prescription.

Description

Alluzience 125 Speywood Units is a ready-to-use botulinum toxin type A solution for injection from Galderma. This listing contains one 125 Speywood Unit vial for professional use.

Ready-to-use Alluzience presentation

Unlike botulinum toxin products supplied as powders for reconstitution, Alluzience is supplied as a ready-to-use solution for injection. Practitioners should consult the current Summary of Product Characteristics (SmPC) for authorised indications, dosing, contraindications, warnings, storage and administration information.

Botulinum toxin potency units are product-specific and must not be treated as interchangeable between different toxin medicines.

Professional pharmacy supply

Alluzience is a prescription-only medicine (POM). Longeva Pharma is a UK GPhC-registered pharmacy and supplies POMs to eligible professional customers only through the appropriate prescription, pharmacist-review and pharmacy route.

Browse the complete Botulinum Toxins & Diluents range or explore the Galderma aesthetic products portfolio, including Azzalure, Alluzience and Relfydess.

Compare Alluzience with other botulinum toxins

Practitioners comparing the major UK toxin products can read our botulinum toxin brands comparison. For pharmacy and supplier considerations, see Where to Buy Botulinum Toxin in the UK.

Product information

  • Manufacturer: Galderma
  • Presentation: One vial
  • Strength: 125 Speywood Units
  • Pharmaceutical form: Solution for injection
  • Legal category: Prescription-only medicine (POM)

Regulatory information: Consult the current Alluzience SmPC before prescribing or using the medicine.

Report suspected adverse reactions via the MHRA Yellow Card Scheme.

Prescription supply

Prescription-only medicines (POM) are always dispensed against a valid, patient-specific prescription and are never available as clinic stock, under any circumstances.

Where a product genuinely supports both routes, you choose whether you are ordering that item on prescription for a named patient or as clinic stock under your professional responsibility when you select it on the product page.

Named-patient prescription supply. Items chosen for a named patient are dispensed against your prescription. The order is held for Superintendent Pharmacist review before despatch. Prescription supply is zero-rated for VAT.

Clinic stock supply. Where eligible, items chosen as clinic stock are supplied under your professional responsibility for use in your practice. Standard VAT applies at checkout. This route is never offered for prescription-only medicines.

Orders containing prescription-only medicines are held until the Superintendent Pharmacist has cleared the prescription. Same-day dispatch applies once cleared.

For questions about prescription supply, contact admin@longevapharma.com or reply to your order confirmation email.

Delivery & Returns

Delivery: Dispatch and delivery depend on stock, cleared payment, customer eligibility and any required prescription or pharmacy checks. Delivery estimates are not guarantees. See our Shipping and Delivery Policy.

Returns: Because storage history, product integrity, traceability and chain of custody cannot be verified after regulated healthcare goods leave our control, medicines, cold-chain goods, sterile products, injectables and other regulated products cannot normally be returned after dispatch. This does not affect remedies for goods supplied incorrectly, damaged or defective. See our Returns and Refunds Policy.

Cold chain: Temperature-sensitive products must be received promptly and transferred to the required storage conditions. If damage or a suspected temperature excursion is identified, quarantine the goods, retain all packaging and contact Longeva Pharma before use.

You may also like